Novavax to Seek Emergency Use Authorization for COVID-19 Vaccine in 3rd Quarter
There could soon be a fourth COVID-19 vaccine available in the U.S.
Novavax is applying for emergency use authorization for its COVID-19 vaccine during the third quarter this year.
The company originally planned to apply for authorization in the U.S. during the second quarter but had delays getting manufacturing data.
In the meantime, Novavax says it will be stockpiling tens of millions of doses.